2718 Federal Register / Vol. 80, No. 12 / Tuesday, January 20, 2015 / Notices 

Office of Human Resources (RB6) 

(1) Provides advice and guidance on 

all aspects of the HRSA human 

resources management program; (2) 

provides the full range of human 

resources operations including: 

employment; staffing and recruitment; 

compensation; classification; executive 

resources; labor and employee relations; 

employee benefits; and retirement; (3) 

develops and coordinates the 

implementation of human resources 

policies and procedures for HRSA’s 

human resources activities; (4) 

monitors, evaluates, and reports on the 

effectiveness, efficiency, and 

compliance with HR laws, rules, and 

regulations; (5) provides advice and 

guidance for the establishment or 

modification of organization structures; 

(6) manages the HRSA’s Ethics Program; 

(7) administers the agency’s 

performance management programs; (8) 

manages the incentive and honor 

awards programs; (9) represents HRSA 

in human resources matters both within 

and outside of the Department; (10) 

oversees the commissioned corps 

liaison activities including the day-today operations of workforce 

management; (11) monitors HR 

accountability; (12) manages HR 

information technology; (13) provides 

staff support to the Deputy Ethics 

Counselor; (14) directs, coordinates, and 

conducts workforce development 

activities for the agency and (15) 

conducts HRSA-wide workforce 

analysis studies and surveys. 

Division of HR Operations (RB61) 

The Division of HR Operations is 

responsible for providing advice, 

guidance and advisory services on 

human resources activities. (1) Provides 

the full range of human resources 

operations activities including: 

employment; staffing and recruitment; 

compensation; classification; and 

personnel action processing; (2) 

develops and implements human 

resources policies and procedures for 

classification, and staffing and 

recruitment; (3) provides expert 

guidance to managers on the 

recruitment process; and (4) ensures 

human resources staff is meeting 

customer service and performance 

expectations. 

Division of Workforce Relations (RB62) 

The Division of Workforce Relations 

is responsible for providing advice, 

guidance, and counsel to agency 

employees and managers. (1) Represents 

HRSA on human resources matters 

before the Department, the Office of the 

General Counsel, the Office of 

Government Ethics, the Office of 

Personnel Management, the unions, and 

the Federal Labor Relations Authority; 

(2) provides human resources to 

managers and employees, including: 

labor relations, employee relations, 

performance management, employee 

benefits, and retirement; (3) manages the 

unemployment and voluntary leave 

transfer programs; (4) manages the 

HRSA-wide ethics program; (5) 

administers the performance 

management programs; (6) manages 

commissioned corps liaison activities; 

and (7) manages HRSA’s Telework 

Program. 

Division of HR Policy and Technology 

(RB63) 

The Division of HR Policy and 

Technology: (1) Develops and 

implements HRSA-wide human 

resources policies; (2) establishes 

standard operating procedures for the 

human resources office; (3) guides the 

identification, review, and 

implementation of HR information 

technology that enables workforce 

empowerment and supports HR in 

achieving its ability to execute a variety 

of duties efficiently and effectively; (4) 

manages an accountability program that 

includes preparation and responses to 

audits and reviews; (5) manages the 

incentive and honor awards programs; 

(6) manages the HR helpdesk by 

providing timely, reliable, and accurate 

HR-related information to customers 

and other stakeholders; (7) manages the 

executive resources functions to include 

recruitment, staffing, and performance 

management; and (8) works on HR 

projects and initiatives. 

Division of Workforce Development 

(RB64) 

(1) Establishes long-term workforce 

skills and capacity building strategies; 

(2) plans, directs, manages, evaluates 

HRSA-wide learning programs, 

technical, career growth and leadership 

development programs; (3) develops, 

designs, implements, and evaluates a 

comprehensive strategic workforce 

leadership development and career 

management program for all 

occupational series throughout HRSA; 

(4) provides technical assistance and 

recommendations in creating highperformance in organizations, career 

management, and employee learning 

and development; (5) maximizes 

economies of scale through systematic 

planning and evaluation of agency-wide 

learning and leadership development 

initiatives; (6) identifies and assesses 

relevant scanning/benchmarking on 

workforce and career development 

processes, services and products; (7) 

establishes policies governing major 

learning initiatives and new learning 

activities, and works collaboratively 

with other components of HRSA in 

planning, developing, implementing, 

and evaluating policies related to 

professional development initiatives; (8) 

plans, directs, and manages HRSA-wide 

skills-building and service programs for 

fellows and interns; (9) conducts 

agency-wide workforce analysis studies 

and surveys; (10) develops 

comprehensive workforce capacitybuilding strategies that meet the 

requirements of the Office of Personnel 

Management and the Department of 

Health and Human Services, 

programmatic needs of HRSA, and the 

governance and management needs of 

HRSA leadership; and (11) evaluates 

workforce capacity-building strategies to 

ensure that HRSA is able to retain a 

cadre of talented and ready public 

health professionals, reduce risks 

associated with turnover in mission 

critical positions and create a match 

between future needs and the 

aspirations of individuals. 

Section RB–30, Delegations of Authority 

All delegations of authority and redelegations of authority made to HRSA 

officials that were in effect immediately 

prior to this reorganization, and that are 

consistent with this reorganization, 

shall continue in effect pending further 

re-delegation. 

This reorganization is effective upon 

date of signature. 

Dated: January 12, 2015. 

Mary K. Wakefield, 

Administrator. 

[FR Doc. 2015–00710 Filed 1–16–15; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; Notice 

of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 


rljohnson on DSK3VPTVN1PROD with NOTICES
Federal Register / Vol. 80, No. 12 / Tuesday, January 20, 2015 / Notices 2719 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel; PAR–14–257: 

Research Using Biosamples from Selected 

Type 1 Diabetes Clinical Studies (DP3). 

Date: February 13, 2015. 

Time: 12:00 p.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, Two 

Democracy Plaza, 6707 Democracy 

Boulevard, Bethesda, MD 20892, (Telephone 

Conference Call). 

Contact Person: Dianne Camp, Ph.D., 

Scientific Review Officer, Review Branch, 

DEA, NIDDK, National Institutes of Health, 

Room 756, 6707 Democracy Boulevard, 

Bethesda, MD 20892–2542, 301–594–7682, 

campd@extra.niddk.nih.gov. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel; PAR–14–258: 

Research Using Subjects from Selected Type 

1 Diabetes Clinical Studies (DP3). 

Date: February 18, 2015. 

Time: 12:00 p.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, Two 

Democracy Plaza, 6707 Democracy 

Boulevard, Bethesda, MD 20892, (Telephone 

Conference Call). 

Contact Person: Dianne Camp, Ph.D., 

Scientific Review Officer, Review Branch, 

DEA, NIDDK, National Institutes of Health, 

Room 756, 6707 Democracy Boulevard, 

Bethesda, MD 20892–2542, 301–594–7682, 

campd@extra.niddk.nih.gov. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel; Closed Loop 

Technologies: Clinical. 

Date: March 6, 2015. 

Time: 10:00 a.m. to 1:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, Two 

Democracy Plaza, 6707 Democracy 

Boulevard, Bethesda, MD 20892, (Telephone 

Conference Call). 

Contact Person: Elena Sanovich, Ph.D., 

Scientific Review Officer, Review Branch, 

DEA, NIDDK, National Institutes of Health, 

Room 750, 6707 Democracy Boulevard, 

Bethesda, MD 20892–2542, 301–594–8886, 

sanoviche@mail.nih.gov. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel; Digestive Diseases 

Research Core Centers. 

Date: March 26–27, 2015. 

Time: 6:00 p.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Residence Inn Bethesda, 7335 

Wisconsin Avenue, Bethesda, MD 20814. 

Contact Person: Maria E. Davila-Bloom, 

Ph.D., Scientific Review Officer, Review 

Branch, DEA, NIDDK, National Institutes of 

Health, Room 758, 6707 Democracy 

Boulevard, Bethesda, MD 20892–5452, (301) 

594–7637, davila-bloomm@

extra.niddk.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research; 93.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS) 

Dated: January 13, 2015. 

David Clary, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2015–00652 Filed 1–16–15; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel Small 

Grants Program for Cancer Epidemiology 

(R03) Review at NCI. 

Date: February 24, 2015. 

Time: 9:00 a.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute Shady 

Grove, 9609 Medical Center Drive, Room 

4W030, Rockville, MD 20850, (Telephone 

Conference Call). 

Contact Person: Scott A. Chen, Ph.D. 

Scientific Review Officer, Division of 

Extramural Activities, National Cancer 

Institute, 9609 Medical Center Drive, Room 

7W604 Rockville, MD 20850, 240–276–6038 

chensc@mail.nih.gov. 

Information is also available on the 

Institute’s/Center’s home page: http://

deainfo.nci.nih.gov/advisory/sep/sep.htm, 

where an agenda and any additional 

information for the meeting will be posted 

when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: January 13, 2015. 

Melanie J. Gray, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2015–00650 Filed 1–16–15; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Neurological 

Disorders and Stroke Amended; Notice 

of Meeting 

Notice is hereby given of a change in 

the meeting of the Neurological 

Sciences and Disorders C, February 26, 

2015, 08:00 a.m. to February 27, 2015, 

06:00 p.m., Embassy Suites Alexandria, 

Alexandria, VA which was published in 

the Federal Register on January 6, 2015, 

80 FR 513. 

The meeting date has been changed 

from February 26–27, 2015 to March 

30–31, 2015. The location remains the 

same. The meeting is closed to the 

public. 

Dated: January 13, 2015. 

Carolyn Baum, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2015–00671 Filed 1–16–15; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Amended 

Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the Center for Scientific 

Review Special Emphasis Panel, 

February 6, 2015, 11:00 a.m. to February 

6, 2015, 01:00 p.m., National Institutes 

of Health, 6701 Rockledge Drive, 

Bethesda, MD 20892 which was 

published in the Federal Register on 

January 8, 2015, 80 FR 1031. 

The meeting will be held on February 

11, 2015. The meeting location and time 

remain the same. The meeting is closed 

to the public. 

Dated: January 13, 2015. 

Melanie J. Gray, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2015–00651 Filed 1–16–15; 8:45 am] 

BILLING CODE 4140–01–P 


rljohnson on DSK3VPTVN1PROD with NOTICES